Abnormal processing of IL-1β in NLRP7-mutated monocytes in hydatidiform mole patients

© 2020 British Society for Immunology..

NOD-like receptor pyrin 7 (NLRP7) has been identified as the major gene responsible for the recurrent hydatidiform mole (RHM). The immunological role of NLRP7 mutation in HM patients has not been conclusively demonstrated. Hence, we aim to demonstrate this role in our study. We followed 12 new patients with NLRP7 non-synonymous variations (NSVs) from date to date. Peripheral blood mononuclear cells (PBMCs) were collected separately from patients with and without NLRP7 mutation. Supernatant interleukin (IL)-1β secretion, intracellular pro-IL-1β and mature IL-1β expressions were measured after 24 h lipopolysaccharide (LPS) stimulation. Plasmids with corresponding NSVs were generated to evaluate the ability of processing pro-IL-1β into mature IL-1β in vitro. Homozygous or compound heterozygous NLRP7 mutations secreted less IL-1β in roots of abnormal intracellular pro-IL-1β or mature IL-1β, according to different domains. Plasmids with NSVs could also affect processing or/and trafficking together with caspase-1 and apoptosis-associated speck-like protein (ASC). Inflammasome-related NLRP7 mutation is a potential mechanism of RHM.

Errataetall:

ErratumIn: Clin Exp Immunol. 2021 May;204(2):283. - PMID 33890286

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:202

Enthalten in:

Clinical and experimental immunology - 202(2020), 1 vom: 01. Okt., Seite 72-79

Sprache:

Englisch

Beteiligte Personen:

Zhang, P [VerfasserIn]
Zhu, X [VerfasserIn]
Yu, X [VerfasserIn]
Huang, B [VerfasserIn]
Jiang, T [VerfasserIn]
Zhang, X [VerfasserIn]
Yang, H [VerfasserIn]
Qian, J [VerfasserIn]

Links:

Volltext

Themen:

Adaptor Proteins, Signal Transducing
Hydatidiform mole
IL-1β
IL1B protein, human
Interleukin-1beta
Journal Article
NLRP7
NLRP7 protein, human
Neoplasm Proteins

Anmerkungen:

Date Completed 19.01.2021

Date Revised 02.10.2021

published: Print-Electronic

ErratumIn: Clin Exp Immunol. 2021 May;204(2):283. - PMID 33890286

Citation Status MEDLINE

doi:

10.1111/cei.13472

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM310645573